Swiss National Bank’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.54M Hold
199,100
﹤0.01% 1468
2025
Q1
$3.55M Sell
199,100
-3,100
-2% -$55.2K ﹤0.01% 1445
2024
Q4
$6.03M Buy
202,200
+2,600
+1% +$77.5K ﹤0.01% 1209
2024
Q3
$3.12M Hold
199,600
﹤0.01% 1601
2024
Q2
$3.42M Hold
199,600
﹤0.01% 1514
2024
Q1
$3.12M Hold
199,600
﹤0.01% 1592
2023
Q4
$2.98M Sell
199,600
-22,000
-10% -$328K ﹤0.01% 1619
2023
Q3
$3.58M Sell
221,600
-119,700
-35% -$1.93M ﹤0.01% 1484
2023
Q2
$14.2M Sell
341,300
-32,600
-9% -$1.35M 0.01% 747
2023
Q1
$22.5M Sell
373,900
-9,200
-2% -$553K 0.02% 614
2022
Q4
$28.1M Sell
383,100
-23,948
-6% -$1.76M 0.02% 571
2022
Q3
$30.9M Sell
407,048
-300
-0.1% -$22.8K 0.02% 554
2022
Q2
$28.3M Buy
407,348
+2,600
+0.6% +$181K 0.02% 576
2022
Q1
$33.5M Buy
404,748
+50,300
+14% +$4.17M 0.02% 584
2021
Q4
$26.6M Sell
354,448
-13,600
-4% -$1.02M 0.02% 622
2021
Q3
$42.8M Sell
368,048
-7,800
-2% -$906K 0.03% 528
2021
Q2
$83.4M Buy
375,848
+43,048
+13% +$9.55M 0.05% 360
2021
Q1
$44M Buy
332,800
+8,300
+3% +$1.1M 0.03% 523
2020
Q4
$56.2M Buy
324,500
+131,000
+68% +$22.7M 0.04% 439
2020
Q3
$21.5M Buy
193,500
+4,400
+2% +$490K 0.02% 603
2020
Q2
$11.2M Buy
189,100
+35,500
+23% +$2.11M 0.01% 728
2020
Q1
$10.3M Buy
153,600
+3,200
+2% +$215K 0.01% 663
2019
Q4
$12.7M Buy
150,400
+6,200
+4% +$522K 0.01% 687
2019
Q3
$10.8M Buy
144,200
+2,800
+2% +$209K 0.01% 732
2019
Q2
$8.94M Buy
141,400
+22,700
+19% +$1.44M 0.01% 801
2019
Q1
$5.72M Buy
118,700
+4,200
+4% +$202K 0.01% 1003
2018
Q4
$3.83M Buy
114,500
+5,000
+5% +$167K ﹤0.01% 1140
2018
Q3
$5.74M Hold
109,500
0.01% 1023
2018
Q2
$3.43M Buy
109,500
+32,100
+41% +$1M ﹤0.01% 1356
2018
Q1
$1.69M Buy
77,400
+3,700
+5% +$80.6K ﹤0.01% 1753
2017
Q4
$1.49M Hold
73,700
﹤0.01% 1838
2017
Q3
$1.46M Buy
73,700
+3,200
+5% +$63.5K ﹤0.01% 1827
2017
Q2
$1.22M Hold
70,500
﹤0.01% 1916
2017
Q1
$571K Hold
70,500
﹤0.01% 2330
2016
Q4
$553K Hold
70,500
﹤0.01% 2346
2016
Q3
$602K Hold
70,500
﹤0.01% 2255
2016
Q2
$823K Buy
+70,500
New +$823K ﹤0.01% 2076